DHT blockers are medications, supplements, or topical products that reduce levels of dihydrotestosterone, a hormone responsible for hair loss and prostate enlargement. They work by targeting the enzyme that converts testosterone into DHT, and they’re one of the most effective treatments available for slowing or reversing male pattern hair loss.
How DHT Drives Hair Loss
Your body produces DHT from testosterone using an enzyme called 5-alpha reductase. DHT is a more potent form of testosterone, and it binds to receptors in hair follicles on the top and front of the scalp. Over time, this causes the follicles to shrink, producing thinner, shorter hairs until they stop growing altogether. This process is called miniaturization, and it’s the core mechanism behind male pattern hair loss.
Not everyone is equally affected. Men with pattern hair loss are genetically predisposed to have higher levels of the 5-alpha reductase enzyme and more active hormone receptors in their scalp follicles. That’s why two men with similar testosterone levels can have very different hairlines. The issue isn’t how much testosterone you produce; it’s how much gets converted to DHT and how sensitive your follicles are to it.
Prescription DHT Blockers
The two main prescription options are finasteride and dutasteride. Both block the 5-alpha reductase enzyme, but they differ in how thoroughly they do it. Finasteride targets only one version of the enzyme (type 2), reducing DHT levels by about 70%. Dutasteride blocks both type 1 and type 2, bringing DHT down by roughly 90%. In practice, this makes dutasteride more powerful at suppressing DHT, though finasteride remains the more commonly prescribed option for hair loss.
These medications don’t just lower DHT in your blood. They reduce it directly within scalp tissue and, in the case of prostate treatment, within the prostate itself. Finasteride at standard doses has been shown to reduce DHT inside the prostate by 80 to 91%, while dutasteride reduces it by about 94%.
Topical vs. Oral Options
For people concerned about whole-body effects, topical finasteride offers a middle ground. A phase III clinical trial found that a topical spray delivered similar hair growth results to oral finasteride, but with far less impact on the rest of the body. After 24 weeks, topical finasteride reduced blood DHT levels by about 35%, compared to 56% with the oral version. Peak drug levels in the blood were over 100 times lower with the topical form.
This matters because most side effects of DHT blockers are tied to how much the drug circulates throughout your system. A topical application concentrates the effect on the scalp while keeping systemic exposure low.
Natural DHT Blockers
Several supplements are marketed as natural alternatives, and a few have clinical evidence behind them. Pumpkin seed oil is the strongest example. In a randomized, placebo-controlled trial, men who took 400 mg of pumpkin seed oil daily for 24 weeks saw a 40% increase in hair count, compared to 10% in the placebo group. That’s a meaningful difference, though still less dramatic than what prescription drugs typically deliver.
Saw palmetto, an extract from the berries of a small palm tree, is another popular option. One study found that 38% of men taking 320 mg daily for two years showed increased hair growth. That’s a more modest response rate than prescription blockers, but it does suggest a real, if limited, effect.
Green tea contains a compound called EGCG that has been shown to inhibit the 5-alpha reductase enzyme in hair follicles. However, most of the evidence for EGCG comes from lab studies rather than large clinical trials, so its real-world effectiveness for hair loss is less certain than pumpkin seed oil or saw palmetto.
How Long Before You See Results
DHT blockers require patience. With standard oral finasteride combined with minoxidil, most clinicians expect four to six months before significant, visible hair regrowth appears. Some people notice reduced shedding earlier, within the first one to three months, but the hair growth cycle is slow and new hairs take time to reach a visible length.
It’s common to experience a temporary increase in shedding during the first few weeks. This happens because weaker, miniaturized hairs are pushed out as follicles begin producing healthier ones. It’s generally a sign that the treatment is working, not failing.
Side Effects and Safety
The most discussed side effects of prescription DHT blockers are sexual in nature: reduced libido, difficulty with erections, or changes in ejaculation. In a large clinical trial, 15% of men on finasteride reported sexual side effects during the first year, compared to 7% on placebo. That’s a real difference, but it also means most of the gap is smaller than many people assume. After the first year, the rate of new sexual side effects was identical between the drug and placebo groups, at 7% each.
Long-term safety data is generally reassuring. A study following men for a median of nearly seven years found no increased risk of aggressive disease in those using these medications. The drugs continued to work over time without new safety signals emerging.
DHT Blockers for Prostate Health
DHT doesn’t just affect hair follicles. It’s the primary driver of prostate growth, both normal and abnormal. In men with benign prostatic hyperplasia (an enlarged prostate causing urinary symptoms), DHT blockers shrink the prostate by reducing the hormone levels inside the tissue. This slows progression and can improve symptoms like frequent urination and weak urine flow.
Higher doses are typically used for prostate conditions than for hair loss. In direct comparisons for prostate treatment, dutasteride suppressed blood DHT by 95% compared to 71% for finasteride. Both effectively caused the prostate tissue to shrink over time.
DHT Blockers for Women
Women also experience hormone-related hair loss, called female pattern hair loss, though the treatment approach differs. Finasteride and dutasteride are not used in women who are or could become pregnant, because reducing DHT can cause serious birth defects in male fetuses.
Instead, a medication called spironolactone is the most common anti-androgen used for women’s hair loss. It works differently, blocking the hormone receptor rather than the enzyme. A meta-analysis found that about 57% of women treated with spironolactone saw improvement, with even better results (around 66%) when it was combined with other therapies. Hair loss worsened in fewer than 4% of treated women. Individual studies have reported even higher stabilization rates, with 74 to 80% of women seeing their hair loss stop progressing or improve.